Safe Oxycodone Tapering Strategies

Tapering Approach

The American Academy of Medicine recommends using a hyperbolic taper of 10% per month or slower for long-term oxycodone users, with each new dose being 90% of the previous dose 1
The Centers for Disease Control and Prevention suggests that very slow tapers with pauses may be necessary to allow gradual accommodation to lower doses 2

The British Journal of Anaesthesia recommends weaning opioids first, then stopping NSAIDs, and finally stopping acetaminophen when reducing postoperative or post-procedural pain medications 3
The Mayo Clinic Proceedings suggests that small dose decreases initially can address patient anxiety and build confidence in the tapering process 1

The Mayo Clinic Proceedings warns that never abruptly discontinuing oxycodone in physically-dependent patients is unacceptable medical care and carries overdose risk 1
The British Journal of Anaesthesia recommends prescribing no more than 5-7 days of opioids to minimize physical dependence in postoperative patients 3
The Mayo Clinic Proceedings suggests considering switching to buprenorphine/naloxone for a controlled transition off full opioid agonists if tapering fails 1
The MMWR Recommendations and Reports advises remaining alert for unmasked anxiety, depression, or opioid use disorder that may emerge during tapering 2

The Mayo Clinic recommends monitoring for withdrawal symptoms, including dysphoria, irritability, insomnia, anhedonia, or a vague sense of being unwell, during opioid tapering 4
The Mayo Clinic also recommends monitoring for anxiety, muscle aches, and sweating as potential withdrawal symptoms during opioid tapering 4
For patients on opioids for years, a taper of 10% per month or slower is often required, taking several months to years 4, 5

The Mayo Clinic recommends considering clonidine or tizanidine for general withdrawal symptoms, trazodone for insomnia, gabapentin for anxiety and irritability, and loperamide for gastrointestinal discomfort during opioid tapering 4

The CDC recommends a 10% per week taper for chronic pain patients on long-term therapy, which is not suitable for short-term users 4
Patients with short-term opioid use, such as 3 weeks, have minimal physical dependence and can taper more rapidly than long-term users 4, 5

The CDC guidelines recommend that once the smallest available dose is reached, the interval between doses can be extended before stopping entirely, as part of a tapering strategy for patients on oxycodone for months to years 6
For long-term use, a slower taper of 10% of the current dose per week minimum, or 10% per month for patients on opioids for years, is recommended by the CDC and other guidelines 6, 7

Monitor for withdrawal symptoms at each dose reduction, including drug craving, anxiety, insomnia, abdominal pain, vomiting, diarrhea, diaphoresis, mydriasis, tremor, and tachycardia, as recommended by the CDC and the American Academy of Sleep Medicine 7, 8
If withdrawal symptoms occur, immediately return to the previous dose and slow the taper by either increasing the interval between reductions, decreasing the amount of dose change, or both, to minimize the risk of severe withdrawal symptoms and overdose 6, 7

The CDC and the FDA recommend avoiding abrupt discontinuation of oxycodone in physically-dependent patients, as it can lead to severe withdrawal symptoms, increased overdose risk, and patient abandonment 6, 7
Avoid using rigid schedules and prioritize patient tolerance and progress over speed, as recommended by the CDC and the American Academy of Sleep Medicine 6, 7

Concurrent cognitive-behavioral therapy can significantly increase successful opioid discontinuation rates and should be offered when available, as recommended by the American Academy of Sleep Medicine and the CDC 6, 8